Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving cardiac function in high-risk surgical patients with bisoprolol
2017-002443-15Phase 4Terminated
- Sponsor
- York and Scarborough Teaching Hospitals NHS Foundation Trust
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bisoprolol in cardiac morbidity, sponsored by York and Scarborough Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in VE/VCO2 at anaerobic threshold or nadir. Started Sep 2017; status: terminated.
02
Drugs
bisoprolol
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2017-002443-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002443-15.